BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, June 19, 2026
Home » Authors » Shannon Ellis

Articles by Shannon Ellis

China tackles corruption in clinical trials with new rules for hospitals, docs

Nov. 11, 2014
By Shannon Ellis
SHANGHAI – China's hospitals are now required to centralize financial management of clinical trials, set up an enhanced supervision system and strengthen their use of project management tools.
Read More

Johnson & Johnson aims to accelerate innovation in Asia

Nov. 4, 2014
By Shannon Ellis

SHANGHAI – Shanghai is the final leg of Johnson & Johnson's world tour of innovation hot spots – having just cut the ribbon on its fourth J&J Innovation Centre after doing so in London, Boston and California. The Asia Pacific Innovation Center promises to open up J&J resources to the region's best minds in pharmaceuticals, medical devices and health care products. Their aim is clear, to close the gaps in the life sciences ecosystem to accelerate innovation.


Read More

Johnson & Johnson aims to accelerate innovation in Asia

Nov. 4, 2014
By Shannon Ellis
SHANGHAI – Shanghai is the final leg of Johnson & Johnson's world tour of innovation hot spots – having just cut the ribbon on its fourth J&J Innovation Centre after doing so in London, Boston and California.
Read More

China's Betta buys into Xcovery's ALK inhibitor with $20M investment

Oct. 30, 2014
By Shannon Ellis

SHANGHAI – Biotech acquisitions are increasingly becoming a part of the Chinese outbound investment story. This time around, up and comer Betta Pharmacuetical Co., of Hangzhou, Zhejiang, has made a $20 million equity investment in Xcovery Inc., of West Palm Beach, Fla.


Read More

China's cross-border partnering deals set to break record in 2014

Oct. 29, 2014
By Shannon Ellis
SUZHOU, China – The China growth story continues to buoy the life science industry, even in the face of challenging headwinds of change. That was the message from PwC experts who extensively surveyed executives and innovators across device, service, venture capital and pharma, many of whom were in the room for the recent collegial ChinaBio Leadership Retreat in Changshu.
Read More

China's cross-border partnering deals set to break record in 2014

Oct. 29, 2014
By Shannon Ellis
SUZHOU, China – The China growth story continues to buoy the life science industry, even in the face of challenging headwinds of change. That was the message from PwC experts who extensively surveyed executives and innovators across device, service, venture capital and pharma, many of whom were in the room for the recent collegial ChinaBio Leadership Retreat in Changshu.
Read More

China's Betta buys into Xcovery's ALK inhibitor with $20M investment

Oct. 29, 2014
By Shannon Ellis
SHANGHAI – Biotech acquisitions are increasingly becoming a part of the Chinese outbound investment story. This time around, up and comer Zhejiang Betta Pharmacuetical Co. has made a commitment to invest $20 million in equity in Xcovery Inc., of West Palm Beach, Fla.
Read More

Chinese life science leaders, optimistic, working for change

Oct. 22, 2014
By Shannon Ellis
SUZHOU, China – It might be a leadership retreat with golf and sightseeing on the agenda but that only comes after a day of rolling up sleeves and putting heads together to dig into the task of making China a better place for the life sciences industry.
Read More

Chinese life science leaders, optimistic, working for change

Oct. 22, 2014
By Shannon Ellis
SUZHOU, China – It might be a leadership retreat with golf and sightseeing on the agenda but that only comes after a day of rolling up sleeves and putting heads together to dig into the task of making China a better place for the life sciences industry.
Read More

China gives Rotashield vaccine second chance to protect newborns

Oct. 16, 2014
By Shannon Ellis
SHANGHAI – A Chinese vaccine joint venture (JV), Bravovax Co. Ltd., of Wuhan, has taken on the global rights for a rotavirus vaccine to be administered to newborn infants – the first of its kind to protect infants at birth from potentially life threatening diarrhea leading to severe dehydration.
Read More
Previous 1 2 … 42 43 44 45 46 47 48 49 50 … 68 69 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 18, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 16, 2026
  • Brain with puzzle piece removed

    Gene replacement rescues autism-related phenotypes in mice

    BioWorld Science
    Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
  • Red blood cells, DNA

    For clonal hematopoiesis, epigenetics can be in driver’s seat

    BioWorld Science
    Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
  • Illustration of amyloid plaques in Alzheimer's disease

    Elixiron’s enrupatinib shows upbeat interim phase II AD results

    BioWorld
    Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing